Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers?

Turk J Obstet Gynecol. 2017 Sep;14(3):160-165. doi: 10.4274/tjod.67674. Epub 2017 Sep 30.

Abstract

Objective: To investigate the association of inflammatory markers with severity of intrahepatic cholestasis of pregnancy (ICP).

Materials and methods: This retrospective case-control study was conducted with 229 pregnant women, 84 with ICP, and 145 age-matched healthy pregnant women. Patients were categorized as mild ICP (<40 µmol/L) and severe ICP (≥40 µmol/L) with regard to serum bile acids. Inflammatory markers (neutrophil-to-lymphocyte ratio (NLR), platelet-to- lymphocyte ratio (PLR) and mean platelet volume (MPV), and red blood cell distribution width (RDW) were compared between the groups.

Results: Patients with ICP had significantly decreased RDW and increased white blood cell counts (WBC), MPV and PLR, but no significant changes in NLR. The comparison of mild and severe cases with regard to NLR, PLR, WBC, and RDW was similar (p>0.05). MPV levels were significantly increased in severe group (p<0.05).

Conclusion: WBC, MPV, and PLR were the inflammatory markers significantly increased, and RDW was signifantly reduced in ICP. MPV was the marker that significantly increased with the severity of disease. The use of inflammatory markers in the assessment of perinatal outcomes needs further studies.

Keywords: Cholestasis; inflammation; mean platelet volume; neutrophil-to-lymphocyte ratio; platelet-to-lymphocyte ratio.